Intradiscal Injection of Condoliase Looks Promising for Lumbar Herniation
SI-6603 is administered via a single, direct intradiscal injection.
Diagnosis & Disease Information
Hidden Drugs Found in 3 Supplements Promoted for Joint Pain, Arthritis
Fast-Act Rheuma Capsule, New Fast-Act Rheumatism Capsule, and UA-Block contain active hidden drug ingredients not listed on the product label.
Evidence for Safety, Efficacy of Analgesics for Acute Low Back Pain Is Limited
Researchers sought to evaluate the comparative effectiveness and safety of analgesics for acute low back pain.
FDA Requires Manufacturers to Provide Mail-Back Envelopes for Opioid Disposal
Approval of the modified Opioid Analgesic REMS is expected in 2024.
What This Patient Living With Stiff Person Syndrome Wants Physicians to Know
Lauren McDermott, a patient living with atypical SPS, shares her journey from receiving an official diagnosis to the treatments that help her manage her condition.
FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply
Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.
Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy
It was originally approved in 2019 for the treatment of chronic pain.
Zavzpret Nasal Spray Approved for Acute Treatment of Migraine
Zavzpret (zavegepant) nasal spray is a calcitonin gene-related peptide (CGRP) receptor antagonist.
Social Media Discussions on Meds Give Rise to “Patient Influencers”
To better understand the new phenomenon of “patient influencers”, the authors conducted interviews with individuals who routinely offer advice on health topics on social media.
Amphastar Gets FDA Approval for Intranasal Naloxone Product
The product was designed using the Amphastar’s proprietary nasal delivery device.
- Loading...
Loading...
Loading... 
Loading...